PureTech to Present at the JP Morgan Conference
PureTech Health plc announced that its Chief Executive Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 4:30pm PST. A webcast of the presentation will be available on the company's investor relations website. The company, a biotherapeutics firm, aims to transform innovation into value through a capital-efficient R&D model, having already achieved three U.S. FDA approvals.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced that Robert Lyne, Chief Executive Officer, will present at the 44th annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 4:30pm PST / 7:30pm EST. A webcast of the presentation will be available at https://investors.puretechhealth.com.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.